These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 22494770

  • 1. Early perfusion changes in patients with recurrent high-grade brain tumor treated with Bevacizumab: preliminary results by a quantitative evaluation.
    Vidiri A, Pace A, Fabi A, Maschio M, Latagliata GM, Anelli V, Piludu F, Carapella CM, Giovinazzo G, Marzi S.
    J Exp Clin Cancer Res; 2012 Apr 11; 31(1):33. PubMed ID: 22494770
    [Abstract] [Full Text] [Related]

  • 2. Early biomarkers from dynamic contrast-enhanced magnetic resonance imaging to predict the response to antiangiogenic therapy in high-grade gliomas.
    Piludu F, Marzi S, Pace A, Villani V, Fabi A, Carapella CM, Terrenato I, Antenucci A, Vidiri A.
    Neuroradiology; 2015 Dec 11; 57(12):1269-80. PubMed ID: 26364181
    [Abstract] [Full Text] [Related]

  • 3. Recurrent glioblastoma treated with bevacizumab: contrast-enhanced T1-weighted subtraction maps improve tumor delineation and aid prediction of survival in a multicenter clinical trial.
    Ellingson BM, Kim HJ, Woodworth DC, Pope WB, Cloughesy JN, Harris RJ, Lai A, Nghiemphu PL, Cloughesy TF.
    Radiology; 2014 Apr 11; 271(1):200-10. PubMed ID: 24475840
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Whole-tumor histogram analysis of the cerebral blood volume map: tumor volume defined by 11C-methionine positron emission tomography image improves the diagnostic accuracy of cerebral glioma grading.
    Wu R, Watanabe Y, Arisawa A, Takahashi H, Tanaka H, Fujimoto Y, Watabe T, Isohashi K, Hatazawa J, Tomiyama N.
    Jpn J Radiol; 2017 Oct 11; 35(10):613-621. PubMed ID: 28879406
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Vascular change measured with independent component analysis of dynamic susceptibility contrast MRI predicts bevacizumab response in high-grade glioma.
    LaViolette PS, Cohen AD, Prah MA, Rand SD, Connelly J, Malkin MG, Mueller WM, Schmainda KM.
    Neuro Oncol; 2013 Apr 11; 15(4):442-50. PubMed ID: 23382287
    [Abstract] [Full Text] [Related]

  • 8. Identification of Early Response to Anti-Angiogenic Therapy in Recurrent Glioblastoma: Amide Proton Transfer-weighted and Perfusion-weighted MRI compared with Diffusion-weighted MRI.
    Park JE, Kim HS, Park SY, Jung SC, Kim JH, Heo HY.
    Radiology; 2020 May 11; 295(2):397-406. PubMed ID: 32154775
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Towards optimizing the sequence of bevacizumab and nitrosoureas in recurrent malignant glioma.
    Wiestler B, Radbruch A, Osswald M, Combs SE, Jungk C, Winkler F, Bendszus M, Unterberg A, Platten M, Wick W, Wick A.
    J Neurooncol; 2014 Mar 11; 117(1):85-92. PubMed ID: 24458956
    [Abstract] [Full Text] [Related]

  • 12. Quantitative T1 and T2 mapping in recurrent glioblastomas under bevacizumab: earlier detection of tumor progression compared to conventional MRI.
    Lescher S, Jurcoane A, Veit A, Bähr O, Deichmann R, Hattingen E.
    Neuroradiology; 2015 Jan 11; 57(1):11-20. PubMed ID: 25287076
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Glioblastoma: a method for predicting response to antiangiogenic chemotherapy by using MR perfusion imaging--pilot study.
    Sawlani RN, Raizer J, Horowitz SW, Shin W, Grimm SA, Chandler JP, Levy R, Getch C, Carroll TJ.
    Radiology; 2010 May 11; 255(2):622-8. PubMed ID: 20413772
    [Abstract] [Full Text] [Related]

  • 15. Hypervascular tumor volume estimated by comparison to a large-scale cerebral blood volume radiographic atlas predicts survival in recurrent glioblastoma treated with bevacizumab.
    Leu K, Enzmann DR, Woodworth DC, Harris RJ, Tran AN, Lai A, Nghiemphu PL, Pope WB, Cloughesy TF, Ellingson BM.
    Cancer Imaging; 2014 Nov 14; 14(1):31. PubMed ID: 25608485
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.